期刊
STEM CELLS AND DEVELOPMENT
卷 27, 期 18, 页码 1257-1267出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/scd.2018.0052
关键词
HSC; immunity; microgravity; DNA damage repair; leukemogenesis
资金
- National Aeronautics and Space Administration (NASA) Space Biology Program [NNX17AE49G]
- NASA [1002525, NNX17AE49G] Funding Source: Federal RePORTER
Astronauts on missions beyond low-Earth orbit are exposed to a hostile environment in which they are continually bombarded with unique high-energy species of radiation, while in conditions of microgravity (G), which can alter radiation response and immunity. In the present studies, we examined the impact exposing human hematopoietic stem/progenitor cells (HSC) to G had upon their capacity to repair DNA damage and their ability to generate immune cells critical for mounting an effective antitumor response. To this end, we first treated a human HSC-like cell line with an acute dose of the radiomimetic drug bleomycin, cultured them in normal gravity (1G) or simulated G, and quantitated double-strand breaks through -H2AX foci. Calculating the median fluorescence intensity ratio at 1-to-4h post-bleomycin revealed a 26% decrease in 1G, but a 20% increase in G, suggesting that G compromised HSC DNA damage repair and thus has the potential to enhance the genotoxic effects of space radiation. We next examined whether G negatively affected the development of dendritic cells (DC), critical regulators of both the innate and acquired arms of the immune system. Primary human HSC were cytokine induced in 1G or G and analyzed for generation of plasmacytoid (CD123(+)) and myeloid (CD11c(+)) DC. HSC cultured in 1G gave rise to significantly higher numbers of both myeloid and plasmacytoid DC than those cultured in G, suggesting G impairs production of these critical antigen-presenting cells. Our studies thus indicate that conditions of G present during spaceflight perturb multiple pathways that could potentially enhance astronaut risk from exposure to space radiation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据